Your shopping cart is currently empty

4-Methylumbelliferyl-2-acetamido-2-deoxy-β-D-Glucopyranoside is a fluorogenic substrate for β-hexosaminidases that releases fluorescent 4-methylumbelliferone upon enzymatic cleavage, enabling sensitive quantification of enzyme activity across pH-dependent excitation and emission ranges, and is extensively used in clinical and research assays for GM2 gangliosidoses such as Tay-Sachs disease.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 50 mg | $30 | - | In Stock | |
| 100 mg | $44 | - | In Stock | |
| 500 mg | Preferential | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $30 | - | In Stock |
| Description | 4-Methylumbelliferyl-2-acetamido-2-deoxy-β-D-Glucopyranoside is a fluorogenic substrate for β-hexosaminidases that releases fluorescent 4-methylumbelliferone upon enzymatic cleavage, enabling sensitive quantification of enzyme activity across pH-dependent excitation and emission ranges, and is extensively used in clinical and research assays for GM2 gangliosidoses such as Tay-Sachs disease. |
| In vitro | Method: Enzymatic assays using 4-Methylumbelliferyl-2-acetamido-2-deoxy-β-D-Glucopyranoside as substrate were employed to screen inhibitors against the N-terminal fragment of O-GlcNAcase (nOGA). Result: Compound 4 selectively inhibited nOGA with a Ki of 48 μM, showing 15-fold selectivity over full-length OGA and 10-fold selectivity over lysosomal hexosaminidase[1]. |
| Molecular Weight | 379.36 |
| Formula | C18H21NO8 |
| Cas No. | 37067-30-4 |
| Smiles | O([C@H]1[C@H](NC(C)=O)[C@@H](O)[C@H](O)[C@@H](CO)O1)C=2C=C3C(=CC2)C(C)=CC(=O)O3 |
| Relative Density. | 1.4163 g/cm3 (Estimated) |
| Storage | keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 40 mg/mL (105.44 mM), Sonication is recommended. DMF: 5 mg/mL (13.18 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween-80+45% Saline: 2 mg/mL (5.27 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | ||||||||||||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||||||||||||
DMF/DMSO
DMSO
| |||||||||||||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.